Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2000

View Archived Issues

KF-20444 has potent immunosuppressive activity

Alexion signs transgenic agreement with Genzyme Transgenics

Ligand sells Marathon assets to CoPharma

Lexicon Genetics and Scripps Institute announce functional genomics agreement

Ares-Serono and Alkermes to collaborate on sustained-release formulations of proteins

INDs filed by Anesta for two OTS products

Access files IND for amlexanox oral rinse

Genset and Whitehead Institute collaborate on obesity and diabetes research

Cephalon compounds enhance spinal cord ChAT activity, inhibit kinase activity

Carbapenems synthesized at Merck active against resistant Gram-positive bacteria

PDH activators with benzenesulfonamide structure designed at AstraZeneca

Vertex continues to pursue therapeutically active p38 MAP kinase inhibitors

Esteve presents new COX-2 inhibitor and pharmacological profile

Selective GABA-A alpha5 receptor inverse agonists useful for cognitive impairment

Schering AG expands its presence in Japan

Novo Nordisk demerger: company names, logos revealed

New twist in the mergers saga: Warner-Lambert pursues discussions with Pfizer

Antex creates new antibiotics to combat antibiotic-resistant bacteria

OrthoLogic initiates phase I/II trial of Chrysalin for accelerated tissue repair

Remaking the pharmaceutical industry: two other heavyweights now in merger discussions

Significant progress made in continuing trials of Oralgen/Oralin

Antiobesity effects of LEP-(116-130) do not involve interaction with leptin receptors

Health Canada grants priority review to Vanlev

Carrington completes enrollment for phase III trial of ulcerative colitis treatment

FDA accepts NDA for new Rapamune formulation

Mechanism of MDR reversal by TER-199 under investigation

AltaRex in-licenses antibody from NIH for AIT platform

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...